- Home
- LWAY vs BME Comparison
LWAY vs BME Comparison
Compare LWAY & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LWAY | BME |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.4M | 553.8M |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LWAY | BME |
|---|---|---|
| Price | $25.93 | $46.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | ★ 159.2K | 43.5K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.33 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $103,350,000.00 | N/A |
| Revenue This Year | $16.64 | N/A |
| Revenue Next Year | $17.28 | N/A |
| P/E Ratio | $83.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $35.95 |
| 52 Week High | $34.20 | $46.17 |
Technical Indicators
Market Signals| Indicator | LWAY | BME |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 76.62 |
| Support Level | $22.28 | $39.51 |
| Resistance Level | $27.93 | N/A |
| Average True Range (ATR) | 1.39 | 0.50 |
| MACD | -0.47 | 0.15 |
| Stochastic Oscillator | 26.65 | 93.82 |
Price Performance
Historical ComparisonAbout LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.